Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr 21:7:526.
doi: 10.3389/fpsyg.2016.00526. eCollection 2016.

Treating Post-traumatic Stress Disorder in Patients with Multiple Sclerosis: A Randomized Controlled Trial Comparing the Efficacy of Eye Movement Desensitization and Reprocessing and Relaxation Therapy

Sara Carletto  1 , Martina Borghi  2 , Gabriella Bertino  3 , Francesco Oliva  4 , Marco Cavallo  5 , Arne Hofmann  6 , Alessandro Zennaro  7 , Simona Malucchi  8 , Luca Ostacoli  1
Affiliations

Treating Post-traumatic Stress Disorder in Patients with Multiple Sclerosis: A Randomized Controlled Trial Comparing the Efficacy of Eye Movement Desensitization and Reprocessing and Relaxation Therapy

Sara Carletto et al. Front Psychol. .

Abstract

Objective: Multiple Sclerosis (MS) is a demyelinating autoimmune disease that imposes a significant emotional burden with heavy psychosocial consequences. Several studies have investigated the association between MS and mental disorders such as depression and anxiety, and recently researchers have focused also on Post-traumatic Stress Disorder (PTSD). This is the first study that investigates the usefulness of proposing a treatment for PTSD to patients with MS.

Methods: A randomized controlled trial with patients with MS diagnosed with PTSD comparing Eye Movement Desensitization and Reprocessing (EMDR; n = 20) and Relaxation Therapy (RT; n = 22). The primary outcome measure was the proportion of participants that no longer meet PTSD diagnosis as measured with Clinician Administered PTSD Scale 6-months after the treatment.

Results: The majority of patients were able to overcome their PTSD diagnosis after only 10 therapy sessions. EMDR treatment appears to be more effective than RT in reducing the proportion of patients with MS suffering from PTSD. Both treatments are effective in reducing PTSD severity, anxiety and depression symptoms, and to improve Quality of Life.

Conclusion: Although our results can only be considered preliminary, this study suggests that it is essential that PTSD symptoms are detected and that brief and cost-effective interventions to reduce PTSD and associated psychological symptoms are offered to patients, in order to help them to reduce the psychological burden associated with their neurological condition.

Trial registration: NCT01743664, https://clinicaltrials.gov/ct2/show/NCT01743664.

Keywords: EMDR; PTSD; multiple sclerosis; relaxation therapy; stress.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Flow diagram of the progresss through the phases of the research.
See this image and copyright information in PMC

References

    1. Alonzo A. A. (2000). The experience of chronic illness and post-traumatic stress disorder: the consequences ofcumulative adversity. Soc. Sci. Med. 198250 1475–1484. 10.1016/S0277-9536(99)00399-8 - DOI - PubMed
    1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th Edn Washington DC: American Psychiatric Pub.
    1. American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, DC: American Psychiatric Publishing, Inc.
    1. Andrykowski M. A., Cordova M. J. (1998). Factors associated with PTSD symptoms following treatment for breast cancer: test of the andersen model. J. Trauma. Stress 11 189–203. 10.1023/A:1024490718043 - DOI - PubMed
    1. Andrykowski M. A., Cordova M. J., McGrath P. C., Sloan D. A., Kenady D. E. (2000). Stability and change in posttraumatic stress disorder symptoms following breast cancer treatment: a 1-year follow-up. Psychooncology 9 69–78. 10.1002/(SICI)1099-1611(200001/02)9:1<69::AID-PON439>3.3.CO;2-I - DOI - PubMed

Associated data

LinkOut - more resources